Competitive Advantage

Expanding in fast-growing Chinese healthcare market

Government support includes no-interest loan, tax advantages for five years, and high-tech corporation benefits

Strong R&D team lead by our Chairman & CEO Dr. Lee Huang, who headed research team at Bayer Pharmaceutical (USA) for more than 12 years

Proprietary technology enables low cost, high quality API and innovative formulations for unstable drugs

Experience with Chinese FDA expedites fast approval of first-to-market (FTM) drugs